Ukraine Once Again Proves Its Friendship By Trying To Save The U.S. From Its Own Decadence
Our president is wasting billions he doesn’t have to fight a war he didn’t have to fight.
Join The Resist And Unsubscribe Movement, Cancel Your Streaming And AI Services, Punch Back At Trump’s Out-Of-Control ICE
Trump responds to only one thing: the market.
Context Windows In Legal AI And Why Content Still Determines Quality
Legal teams ask a practical question. If large language models are so capable, why does legal AI still depend on curated content, and why does surfacing that content matter so much?
What Experts Say About Hims & Hers’ $1.15B Acquisition Of Eucalyptus
Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges.
Medicare Enrollment For Lawyers: What You Need To Know Before 65
Let's cut through the confusion and focus on what actually matters for your planning.
The Digital Health M&A Wave Is Finally Here
Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say.
Product Spotlight: Lexis® Verdict & Settlement Analyzer
Put away the guesswork—Lexis® Verdict & Settlement Analyzer helps legal professionals assess case potential with confidence by using data-driven insights from the industry’s largest collection of verdicts and settlements.
Finance Bros Rejoice: Polo Ralph Lauren’s Quarter-Zip Was Fashion’s Hottest Product Of Q4 2025
Saint Laurent, Miu Miu, and Cos maintained their top-three positions as fashion's hottest brands for another quarter.
The 4 Biotech Companies On Track To IPO This Week Despite The Government Shutdown
Across all industries, the total number of companies on track to go public could make this week the most active for IPOs since 2021. Despite the partial government shutdown, there are paths biotechs can pursue to the public markets.
Trump Sues JP Morgan For ‘Nice Bank You Got There, Be A Shame If Something Happened To It’
As shakedowns go, it's pretty shakey.
Goldman’s Top Lawyer In The Spotlight Thanks To Epstein Ties
Old associations are resurfacing, raising uncomfortable questions for Wall Street's most powerful bank.
Opus 2 Steps Up Its AI Game With Acquisition Of A Legal Tech Startup
With the addition of Uncover’s technology, the litigation software is delivering rapid innovation.
JPM Deals Recap: Boston Scientific Acquisition, A Mega Round For Parabilis, Enodia Emerges & More
Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup financings announced during the annual J.P. Morgan Healthcare Conference this year.
Reed: Congress ‘Would Have To’ Codify Trump’s Defense Industry Stock Buyback Mandates
The top SASC Democrat stopped short of supporting Trump's executive order, as a few defense firms said they're on board, at least publicly.
Right-Wing’s Fraud Fever Dreams Will Fade Even As Tim Walz’s Decision To Cede Power Goes Down In History
By putting his state above his own ambitions, Tim Walz has ensured that these MAGA lies will swiftly disappear.
If You Are Applying To Law School And Want A Few Minutes Of Free Financial Or Career Advice, Email Me
We can talk about whatever you'd like, be it the financial calculus of going to law school, or how to best set yourself up for the career you want.
Merry Christmas: 2025 Was A Record-Breaking Year For Greed
Greed will keep you in its thoughts and prayers in the new year.